4188 Stock Overview
Develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
AmCad BioMed Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$18.60 |
| 52 Week High | NT$31.00 |
| 52 Week Low | NT$18.75 |
| Beta | 0.89 |
| 1 Month Change | -11.22% |
| 3 Month Change | -14.29% |
| 1 Year Change | -33.57% |
| 3 Year Change | 2.76% |
| 5 Year Change | 47.62% |
| Change since IPO | -70.48% |
Recent News & Updates
Shareholder Returns
| 4188 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -7.7% | -0.7% | -3.4% |
| 1Y | -33.6% | -8.5% | 9.1% |
Return vs Industry: 4188 underperformed the TW Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: 4188 underperformed the TW Market which returned 9.1% over the past year.
Price Volatility
| 4188 volatility | |
|---|---|
| 4188 Average Weekly Movement | 2.6% |
| Medical Equipment Industry Average Movement | 4.2% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4188 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4188's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Yi-Li Lee | www.amcad.com.tw |
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis, and obstructive sleep apnea. The company’s products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients.
AmCad BioMed Corporation Fundamentals Summary
| 4188 fundamental statistics | |
|---|---|
| Market cap | NT$1.20b |
| Earnings (TTM) | -NT$50.58m |
| Revenue (TTM) | NT$53.11m |
22.2x
P/S Ratio-23.3x
P/E RatioIs 4188 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4188 income statement (TTM) | |
|---|---|
| Revenue | NT$53.11m |
| Cost of Revenue | NT$20.17m |
| Gross Profit | NT$32.93m |
| Other Expenses | NT$83.51m |
| Earnings | -NT$50.58m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.80 |
| Gross Margin | 62.02% |
| Net Profit Margin | -95.24% |
| Debt/Equity Ratio | 0% |
How did 4188 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/14 14:58 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AmCad BioMed Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pinghan Hsieh | Capital Securities Corporation |